175 related articles for article (PubMed ID: 35190765)
1. lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.
Wu Y; Fang L; Gao Y; Zhao Z; Zhou L; Zhang G
J Healthc Eng; 2022; 2022():9364467. PubMed ID: 35190765
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NORAD promotes bone marrow stem cell differentiation and proliferation by targeting miR-26a-5p in steroid-induced osteonecrosis of the femoral head.
Fu D; Yang S; Lu J; Lian H; Qin K
Stem Cell Res Ther; 2021 Jan; 12(1):18. PubMed ID: 33413642
[TBL] [Abstract][Full Text] [Related]
3. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
5. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
7. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
Song K; Yu P; Zhang C; Yuan Z; Zhang H
Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FGD5-AS1 Promotes Abdominal Aortic Aneurysm Growth Through the Activation of MMP3 in Vascular Smooth Muscle Cells.
Xu Z; Lang D; Wang D; Hu S; Yang L
Int Heart J; 2023 May; 64(3):470-482. PubMed ID: 37197924
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
10. Lncrna FGD5-AS1 Aggravates Myocardial Ischemia-Reperfusion Injury by Sponging Mir-129-5p.
Wei P; Dong Z; Lou M
Iran J Public Health; 2022 Oct; 51(10):2281-2288. PubMed ID: 36415802
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.
Fei D; Yuan H; Zhao M; Zhao D
Cell Biol Int; 2022 Nov; 46(11):1937-1946. PubMed ID: 36041209
[TBL] [Abstract][Full Text] [Related]
13. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
Fu J; Cai H; Wu Y; Fang S; Wang D
Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
[TBL] [Abstract][Full Text] [Related]
14. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
Yang Y; Sun Z; Liu F; Bai Y; Wu F
Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
[TBL] [Abstract][Full Text] [Related]
16. FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis.
Li J; Wu X; Shi Y; Zhao H
J Orthop Surg Res; 2021 Nov; 16(1):665. PubMed ID: 34772438
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
[TBL] [Abstract][Full Text] [Related]
19. lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes.
Fang XL; Shi SG
Hum Exp Toxicol; 2022; 41():9603271221138969. PubMed ID: 36445031
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
